Chronic quercetin exposure affects fatty acid catabolism in rat lung by Boer, V.C.J., de et al.
Abstract. Dietary quercetin intake is suggested to be 
health promoting, but this assumption is mainly based 
on mechanistic studies performed in vitro. Previously, we 
identified rat lung as a quercetin target tissue. To assess 
relevant in vivo health effects of quercetin, we analyzed 
mechanisms of effect in rat lungs of a chronic (41 weeks) 
1% quercetin diet using whole genome microarrays. 
We show here that fatty acid catabolism pathways, like 
beta-oxidation and ketogenesis, are up-regulated by the 
long-term quercetin intervention. Up-regulation of genes 
(Hmgcs2, Ech1, Acox1, Pcca, Lpl and Acaa2) was veri-
fied and confirmed by quantitative real time PCR. In ad-
dition, free fatty acid levels were decreased in rats fed the 
quercetin diet, confirming that quercetin affects fatty acid 
catabolism. This in vivo study demonstrates for the first 
time that fatty acid catabolism is a relevant process that is 
affected in rats by chronic dietary quercetin.
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Introduction
Flavonoids are polyphenolic compounds of plant origin 
that are present in our diet. Epidemiological studies sug-
gest that a diet rich in flavonoids is protective against car-
diovascular diseases and possibly lung cancer [1]. Mech-
anistic studies show that flavonoids have a wide range of 
properties that can contribute to the potential beneficial 
health effects of flavonoids. For example, they are strong 
antioxidants [2, 3], inhibit tumor formation [4], improve 
endothelial function [5, 6] and affect energy metabolism 
[7]. To elucidate the molecular mechanisms explaining 
the beneficial effects of flavonoids observed in vivo, sev-
eral studies have employed a systems biology approach 
with transcriptomics and proteomics techniques, using 
cell culture systems [8–18]. However, these in vitro stud-
ies may have generated misleading findings due to the 
non-physiological exposure conditions mostly used. In 
the human body, flavonoids are rapidly metabolized and 
therefore flavonoid aglycones (flavonoid molecules with-
out conjugates), frequently used in vitro, are hardly pres-
ent in plasma and tissues [19]. In addition, flavonoids are 
rapidly oxidized under cell culture conditions giving rise 
to oxidation products and H2O2 [20]. This, and the ob-
servation that flavonoid metabolites have profoundly dif-
ferent bioactivities and pharmacokinetics than flavonoid 
aglycones [21–23], suggests that reported mechanisms of 
action of flavonoids based solely on in vitro experiments 
are of limited value.
Quercetin is a flavonol abundant in onions, apples, tea 
and red wine and one of the most studied flavonoids. 
Quercetin is taken up in the intestine and immediately 
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metabolized by phase II enzymes in the intestine and liver 
to methoxy, glucuronic acid and sulfate conjugates [24, 
25]. Chronic treatment of rats with a 0.1% and 1% quer-
cetin diet for 11 weeks resulted in appearance of querce-
tin metabolites in all analyzed tissues. The highest levels 
of quercetin metabolites were found in the lungs [26]. 
For that reason, lung is a relevant in vivo target tissue for 
studying molecular mechanisms underlying the querce-
tin-mediated beneficial health effects using a transcrip-
tomics approach. Only one study on quercetin has used 
an animal model in combination with large scale gene ex-
pression techniques. Mutch et al. [27] showed that expo-
sure of hepatic cytochrome-P450 oxidoreductase-knock-
out and wild-type mice to an acute high dose of quercetin 
(7 mg/mouse), induced alterations in several biological 
pathways in jejunum, colon and liver. Although metabo-
lism of quercetin did not differ between wild-type and 
knockout mice, tissue-specific effects on amino acid me-
tabolism, lipid metabolism, glutathione metabolism and 
antigen presentation were found [27]. This study used an 
acute dose in combination with a genetic intervention.
The aim of our study was to identify, in chronically quer-
cetin administered rats, the relevant in vivo biological 
processes that are regulated by long-term quercetin in-
tervention, mimicking the effects of chronic daily intake 
of quercetin in the diet. We chose lung tissue as a target 
tissue of quercetin action, because the highest concen-
trations of quercetin metabolites were found in lung tis-
sue after chronic dietary supplementation of quercetin 
[26]. In addition, lung tissue seems to be an important 
target based on epidemiological studies indicating that a 
high flavonoid diet is protective against lung cancer [1]. 
We describe the analysis of large-scale gene expression 
changes induced by quercetin in lungs of rats fed a 1% 
quercetin diet (∼500 mg quercetin/kg body weight per 
day) for 41 weeks. We identified pathways affected by 
chronic quercetin intervention and used quantitative real 
time PCR (qRT-PCR) and plasma analysis to confirm the 
effects in these pathways.
Methods
Animal experiment. The animal experiment was per-
formed as previously described [26]. In short, inbred 
male Fisher 344 rats (Charles River Laboratories, Inc., 
Sulzfeld, Germany) were housed in pairs in cages, and 
were fed for 41 weeks a RM3[E]FG SQC breeding diet 
(Special Diets Services, Witham, UK) supplemented 
with 0% (control), 0.1% (w/w) quercetin or 1% (w/w) 
quercetin (six rats per group). Calculated quercetin intake 
for rats fed a 1% quercetin diet were ∼500 mg quercetin/
kg body weight per day and for rats fed a 0.1% quercetin 
diet: ∼50 mg quercetin/kg body weight per day. The con-
trol diet did not contain quercetin or quercetin glycosides 
(data not shown). Animal weight and food intake did not 
differ between control and quercetin intake groups during 
supplementation. After 41 weeks, rats were anaesthetized 
in the morning, without overnight fasting, by inhalation 
of 5% isoflurane, using N2O/O2 (1:1, v/v) as carrier. 
Animals were fully bled via the abdominal aorta. Blood 
(8–12 ml) was collected in EDTA-tubes and plasma was 
subsequently prepared in Leucosep Centrifuge tubes 
(Greiner Bio-one, Longwood, FL, USA) by centrifuging 
for 20 min at 1000 g and 4 °C. Plasma samples were sta-
bilized with ascorbic acid (1 mg/ml plasma final concen-
tration) before storage at –80 °C. After blood collection, 
lungs were dissected and the left and right lungs were 
separately snap frozen in liquid nitrogen and stored at 
–80 °C. The left lung was used for RNA isolation. For the 
microarray experiment, lungs of rats fed a 1% quercetin 
diet and control diet were used. For plasma parameter and 
qRT-PCR analysis all treatment groups (control, 0.1% 
quercetin and 1% quercetin) were used. The experimental 
protocol was approved by the Animal Welfare Commit-
tee of Wageningen University, Wageningen, The Nether-
lands.
RNA isolation. Freeze dried lung tissue was homog-
enized in liquid nitrogen and total RNA was isolated with 
TRIzol (Invitrogen), according to the instructions from 
the manufacturer, with an additional phenol/chloroform/
isoamylalcohol (25:24:1, v:v:v) purification step, fol-
lowed by a second chloroform purification. Integrity and 
quality of RNA samples were checked by gel electropho-
resis and spectrophotometric analysis using a Nanodrop 
(Isogen Life Science). All RNA samples had OD260/280 ra-
tios between 1.9 and 2.1, OD260/230 ratios higher than 1.8, 
and displayed excellent visual integrity.
Microarray. A pooled reference design was used to 
analyze differential lung gene expression in 1% querce-
tin-treated rats vs control rats. All samples were labeled 
individually in duplicate. The protocol described in [28] 
was used with adjustments. In brief, RNA samples (35 µg 
total RNA per sample) from control and 1% quercetin-
treated rats were reverse transcribed and directly labeled 
with Cy5 (Amersham Biosciences) using SuperScript II 
Reverse Transcriptase kit (Invitrogen). A reference pool 
was prepared by mixing equal quantities of total RNA 
from all samples (control group and 1% quercetin group). 
The reference pool was complemented with additional to-
tal RNA isolated from lungs of rats treated with a 1% 
quercetin diet for 1 week to yield a sufficiently large ref-
erence pool. Reference RNA samples (35 µg total RNA 
per sample) were reverse transcribed and labeled with 
Cy3 (Amersham Biosciences). Labeled cDNA samples 
were purified using QIAquick PCR Purification Kit (Qia-
gen) and ethanol precipitation steps. After purification, 
samples were denatured and Cy3-labeled cDNA samples 
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were pooled. Equal volumes of Cy5 target sample and 
Cy3 reference sample were combined, mixed with 2 × hy-
bridization buffer (Agilent Technologies) and 10 × control 
targets (Agilent Technologies) and hybridized to a Whole 
Rat Genome oligo array, containing 44 290 60-mer oligo 
spots (including ∼3000 control spots, G4131A, Agilent 
Technologies), for 17 h at 60 °C in Agilent hybridization 
chambers in an Agilent hybridization oven with rotation 
(Agilent Technologies). After hybridization, microarrays 
were washed with an SSPE wash procedure (Agilent 
Technologies) according to manufacturers protocol and 
scanned with a Scanarray Express HT scanner (Perkin 
Elmer). Signal intensities for each spot were quantified 
using ArrayVision 8.0 (GE Healthcare life sciences). 
Saturated spots and spots with signal intensity lower than 
two times the background were discarded, leaving 33 241 
transcripts for normalization and analysis of differential 
expression. Quality check was performed for each mi-
croarray using both the LimmaGUI package in R [29] 
from the Bioconductor project and Microsoft Excel. The 
best microarray from two duplicates, based on MA plot, 
normal probability plot and signal intensity distribution 
[30, 31], was selected for further analysis. Data normal-
ization was performed according to Pellis et al. [32] using 
GeneMaths XT 1.5 (Applied Maths). Pathway analysis 
was performed using MetaCore (GeneGo). Cluster analy-
sis was performed using GeneMaths XT 1.5. Annotation 
from Agilent (Version 20050601) and TIGR annotations 
from Resourcer [33] were used for gene identification. 
Genes were classified according to gene ontology termi-
nology and literature mining.
Quantitative RT-PCR. Differential expression for in-
dividual genes was assessed by qRT-PCR. cDNA was 
synthesized from 1 µg total RNA for each sample using 
the iScript cDNA Synthesis kit (Bio-Rad). Primers were 
designed for Sybr Green probes with Beacon Designer 
4.0 (Premier Biosoft International) (Table 1). PCR ampli-
fication and detection was performed with the iQ SYBR 
Green Supermix and the MyIQ single-color real-time 
PCR detection system (Bio-Rad). A standard curve for 
all genes including reference genes was generated using 
serial dilutions of a pool prepared from all cDNA sam-
ples. The level of mRNA for each gene was normalized 
using Hmbs and Rps26 as reference genes, chosen on the 
basis of microarray data, which showed similar expres-
sion levels for all microarrays. All samples were analyzed 
within-run in duplicate. PCR amplification and detection 
for all samples and genes was performed in triplicate on 
3 separate days.
Plasma parameters. Plasma levels of free fatty acids, 
triglycerides and β-hydroxybutyrate were analyzed us-
ing commercial kits (WAKO chemicals). Assays were 
adjusted so that small sample volumes could be used and 
analyzed with a microplate reader (BioTec Synergy HT). 
Free fatty acids and triglyceride assays contained ascor-
bate oxidase. Therefore, added vitamin C, up to 1 mg/ml, 
in plasma samples did not interfere in the assays. Vitamin 
C (1 mg/ml) did not interfere in the assay for β-hydroxy-
butyrate (data not shown).
Statistical methods and software. For microarray data 
analysis, p values for differential expression between the 
1% quercetin group (n = 6) and control group (n = 6) 
were calculated using t-test statistics on log intensity val-
ues. Fold changes were calculated using median linear 
signal intensity values. The p value was used to prioritize 
data based on highest significance between the six control 
animals and six quercetin animals. t-test statistics were 
used to test for significant differences in the quantitative 
RT-PCR experiment and plasma parameter analysis, and 
p < 0.05 was considered significant.
Results
Quercetin induced global gene expression changes 
in lungs of rats. We analyzed global gene expression 
changes in lungs of rats fed a quercetin diet for 41 weeks 
using microarrays. From the 33 421 transcripts with sig-
nal intensities above two times the background, 384 genes 
Table 1. Primers used for quantitative real time PCR. All primers were intron-spanning.
Gene symbol Sequence ID Forward primer (5′-3′) Reverse primer (5′-3′) Product 
length (bp)
Lpl NM_012598 TCTGTCACACGTCTAACACATCAC ACAATAGAAGGCTCCTCACTTTGC 191
Ech1 NM_022594 TGTGGTCTCTGGTGCAGGAAAG GGTATCGGCTGATGAGGTCTCG 134
Hmgcs2 NM_173094 GCCTTGGACCGATGCTATGC CTAGGGATTTCTGGACCATCTTGC 145
Acaa2 NM_130433 GGAACACAGGCGACCTTTGAG GTGGTGGCTGCTGACAATGAC 166
Acox1 NM_017340 ACAGTTCTGAGAGCACAGCATC CATTCCAGGAGAAAGGTTAAGGC 108
Pcca XM_341383 AATGGGCAAGGTGAAACTGGTG GTGGTGACTGAAGGGCTACAAG 104
Hmbs NM_013168 TCGCTGCATTGCTGAAAGGG CATCCTCTGGACCATCTTCTTGC 200
Rps26 NM_013224 TCATAGCAAGGTTGTCAGGAATCG CTTTGGTGGAGGTCGTGGTG 103
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were differentially expressed with a fold change higher 
than 1.3-fold. Of these, 34 genes were expressed with a 
fold change higher than 1.5-fold (Fig. 1). Essentially all 
of these genes showed a high variation in expression level 
in both the control and quercetin-treated group (Fig. 1a, 
b), and were therefore not significantly different between 
the two groups. Among the 34 genes with differential ex-
pression higher than 1.5-fold, 13 coded for immunoglob-
ulins, whereas the remaining 21 genes did not belong to 
a common functional category (supplemental Table S1; 
supplemental data are available at www.foodbioactives.
nl). Analysis of the similarities in expression profile of the 
384 genes using hierarchical clustering resulted in group-
ing of 20 immunoglobulin genes up-regulated in the 1% 
quercetin-treated group as compared with the control diet 
group (Table 2). Three additional immunoglobulin genes 
were present in the 384 gene data set, of which 2 were 
down-regulated and 1 did not have a comparable profile. 
The average expression profile of the 20 up-regulated 
immunoglobulins (Fig. 2) illustrated that four animals in 
the control group showed a relatively low expression of 
immunoglobulin genes, whereas two animals showed a 
relatively high immunoglobulin gene expression. In con-
trast, in the quercetin diet group, five animals showed a 
relatively high immunoglobulin gene expression, whereas 
the remaining animal did not. This indicates that the im-
munoglobulin genes were coordinately regulated.
Genes were also ranked on the basis of highest significance 
instead of fold change (Fig. 1c). The 35 genes that were 
most significantly modulated ( p < 0.01, Table 3) belonged 
to various functional categories. However, a group of 5 
Figure 1. Volcano plot of 33 421 transcripts showing the t-test sta-
tistics p value plotted against the fold change of each transcript (1% 
quercetin vs control diet). (a) Genes that are down-regulated (fold 
change < –1.3), (b) genes that are up-regulated (fold change >1.3) 
and (c) genes with a p < 0.05.
Table 2. Twenty up-regulated immunoglobulin genes (1% quercetin 
vs control) that grouped in one cluster. Identified using UPGMA 
clustering with Pearson’s correlation coefficient as distance mea-
sure (384 genes were used with a fold change higher than 1.3). 
Genes are sorted based on cluster order.
Sequence ID Gene name
Z75902 a Immunoglobulin, epsilon chain, variable region 
(clone Hg32)
XM_578308 a Similar to monoclonal antibody kappa light chain
XM_345754 Similar to Ig heavy chain v region VH558 A1/A4 
precursor
AY331040 a Anti-SPE7 immunoglobulin E heavy chain 
 variable region
Z93363 a Immunoglobulin variable region (clone ERF2.37)
XM_234745 a Similar to Ig heavy chain V-I region HG3 
 precursor
BC092586 Similar to immunoglobulin heavy chain 6 (Igh-6)
XM_345756 a Similar to BWK3 ( predicted)
XM_234749 Similar to Ig heavy chain precursor V region 
(IdB5.7)
XM_234686 a Similar to immunoglobulin heavy chain 
XM_345750 Similar to Ig H-chain V-JH3-region
XM_575534 Similar to NGF-binding Ig light chain
S81289 IgM kappa chain variable region  
{CDR1 to CDR3 region}
XM_341195 Immunoglobulin joining chain ( predicted)
Z93359 Immunoglobulin variable region (clone ERF2.13)
AF217591 a Immunoglobulin kappa light chain variable region
X55180 a Monoclonal antibody Y13-259 Vk
XM_575533 a Similar to IG light chain Vk region Y13-259
M84148 a Rat IgK chain VJ1 region
XM_578339 Similar to immunoglobulin kappa-chain
a  Immunoglobulin genes from supplemental Table S1 with fold 
change higher than 1.5.
Figure 2. Relative average expression profile (mean ± SEM) of the 
20 immunoglobulin genes from Table 2. Expression level for each 
gene was normalized using the mean expression level of that gene 
of all arrays (n = 12) (C: rat treated with a control diet for 41 weeks; 
Q: rat treated with a 1% quercetin diet for 41 weeks).
Cell. Mol. Life Sci.  Vol. 63, 2006 Research Article       2851
Table 3. Differentially expressed annotated genes with p < 0.01 in lungs of rats treated with a 1% quercetin diet (n = 6) as compared with 
rats treated with a control diet (n = 6). Genes are ordered based on function and within functional category based on p value.
Gene symbol Gene name Sequence ID p value Fold 
change
Energy metabolism and mitochondrial transport
Atp5j2 ATP synthase, H+ transporting, mitochondrial F0 complex, 
 subunit f, isoform 2
Rn.3543 0.0008 –1.22
Ant2 ADP, ATP carrier protein, fibroblast isoform NM_057102 0.0050 –1.14
Aco1 Aconitase 1 NM_017321 0.0069 1.18
Ech1 Enoyl CoA hydratase 1, peroxisomal NM_022594 0.0082 1.16
Hmgcs2 3-Hydroxy-3-methylglutaryl-CoA synthase 2 NM_173094 0.0085 1.16
Nucleotide metabolism
Dpysl3 Dihydropyrimidinase-like 3 Rn.93365 0.0019 1.26
Tyms Thymidylate synthase NM_019179 0.0039 –1.24
Cell adhesion
Krt2-8 Keratin complex 2, basic, gene 8 BF281337 0.0059 –1.20
Igsf4a_predicted Immunoglobulin superfamily, member 4A ( predicted) Rn.19928 0.0087 1.13
Asb16_predicted Ankyrin repeat and SOCS box-containing 16 ( predicted) AW530584 0.0098 –1.16
Cell proliferation/differentiation
Igfbp3 Insulin-like growth factor binding protein 3 NM_012588 0.0027 1.24
Fhl1 Four and a half LIM domains 1 BC061782 0.0080 1.21
Apoptosis
Casp14_predicted Caspase 14 ( predicted) XM_234878 0.0042 –1.15
Nme6 Expressed in non-metastatic cells 6, protein AI014074 0.0063 –1.12
DNA repair
Pnkp Polynucleotide kinase 3′ -phosphatase NM_001004259 0.0006 1.14
Mbd4_predicted Methyl-CpG binding domain protein 4 ( predicted) XM_342742 0.0035 –1.30
Xpc_predicted Xeroderma pigmentosum, complementation group C ( predicted) XM_232194 0.0067 1.13
Immune response
LOC361454 Chemokine C-C motif receptor-like 1 adjacent CB546044 0.0014 –1.17
Ccl12_predicted Chemokine (C-C motif) ligand 12 ( predicted) XM_213425 0.0065 –1.28
LOC366755 Similar to immunoglobulin heavy chain XM_345742 0.0097 1.86
Protein modification
Gypc_predicted Glycophorin C (Gerbich blood group) ( predicted) AY234182 0.0015 1.15
BRAP2 BRCA1-associated protein BF284618 0.0066 –1.15
Hspcb Heat shock 90 kDa protein 1, beta AI236795 0.0094 –1.20
Pja2 Praja 2, RING-H2 motif containing NM_138896 0.0096 1.09
Receptor
Olr1350 Olfactory receptor 1350 ( predicted) NM_001000752 0.0039 –1.14
Olr197 Olfactory receptor 197 ( predicted) NM_001000188 0.0050 –1.10
Signal transduction
Map2k4_predicted Mitogen-activated protein kinase kinase 4 ( predicted) CA510796 0.0046 1.21
Rit1_predicted Ras-like without CAAX 1 ( predicted) BF406174 0.0057 –1.13
Sorbs1_predicted Sorbin and SH3 domain containing 1 ( predicted) AW917667 0.0068 1.21
Protein transport
Vps39_predicted Vacuolar protein sorting 39 (yeast) ( predicted) XM_342500 0.0054 1.14
Calcium transport
Cacng6 Calcium channel, voltage-dependent, gamma subunit 6 NM_080694 0.0065 1.23
Cytoplasmic metabolism
Ephx2 Epoxide hydrolase 2, cytoplasmic BM986667 0.0078 –1.20
Miscellaneous
Tm7sf1_predicted Transmembrane 7 superfamily member 1 ( predicted) XM_237907 0.0003 1.26
Otos Otospiralin NM_139188 0.0020 –1.21
Tcte1_predicted T-complex-associated testis expressed 1 ( predicted) XM_236941 0.0077 –1.12
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genes (Ech1, Hmgcs2, Ant2, Atp5j2, Aco1) was involved 
in mitochondrial transport and energy metabolism. To get 
more insight whether energy metabolism was affected by 
quercetin intervention, we used a wider criterion for se-
lection of genes ( p < 0.05). Mapping this selection of dif-
ferentially expressed genes (see supplemental Table S2) 
to the Metacore pathway database, containing over 400 
curated pathway maps, showed an over-representation of 
genes involved in lipid metabolism pathways (data not 
shown). This indicated that energy metabolism is indeed 
a major process affected by quercetin.
We identified all genes involved in energy metabolism 
that were regulated by quercetin, and grouped them into 
the pathway diagram shown in Figure 3. Most of the reg-
ulated genes were shown to be involved in the catabolism 
of fatty acids. Quercetin induced both peroxisomal and 
Figure 3. Diagram of fatty acid catabolism. Large arrows indicate up- or down-regulation by treatment of rats with a 1% quercetin diet for 
41 weeks. Genes without an arrow did not change significantly. Ech1 together with Hadh are part of the bifunctional protein. Hadh was up-
regulated as well, but did not pass the significance filtering criteria (data not shown). Acaa1: acetyl-CoA acyltransferase 1; Acaa2: acetyl-
CoA acyltransferase 2; Acad: acetyl-CoA dehydrogenase; Aco1: aconitase 1; Acox1: acyl-CoA oxidase 1; Acs: acyl-CoA synthetase; Ant2: 
adenine nucleotide translocator 2; Atp5j2: ATP synthase (H+ transporting, mitochondrial F0 complex, subunit f, isoform 2); Cact: carni-
tine-acylcarnitine translocase; CptI: carnitine palmitoyltransferase 1; CptII: carnitine palmitoyltransferase 2; Ech1: enoyl CoA hydratase 
1 ( peroxisomal); Echs1: enoyl CoA hydratase (short chain, 1, mitochondrial); Gck: glucokinase; Hadh: hydroxyacyl-CoA dehydrogenase; 
Hibadh: 3-hydroxyisobutyrate dehydrogenase; Hmgcl: 3-hydroxy-3-methylglutaryl-CoA lyase; Hmgcs2: 3-hydroxy-3-methylglutaryl-
CoA synthase 2; Lpl: lipoprotein lipase; Mut: methylmalonyl CoA mutase; Pcca; propionyl CoA carboxylase; Pfk: phosphofructokinase; 
Phgdhl1: phosphoglycerate dehydrogenase like 1; Scot-s: succinyl-CoA:3-ketoacid-CoA transferase 1.
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mitochondrial beta-oxidation genes (Acaa2, Ech1, Acox1 
and Pcca). In addition, the ketogenic pathway was clearly 
up-regulated: Hmgcs2 and Hibadh expression levels were 
mutually increased in quercetin-treated rats, whereas 
Scot-S, the enzyme responsible for the reverse reaction, 
was down-regulated. Upstream of beta-oxidation, two 
important genes were also modulated by quercetin. Li-
poprotein lipase (Lpl) and the gene coding for the chan-
nel importing acyl CoA into mitochondria, Vdac1, were 
both up-regulated by quercetin intervention. Another 
prominent mitochondrial transporter, Ant2, was down-
regulated together with one of the subunits of the ATP 
synthase protein (Atp5j2). These two genes are both part 
of the last step in the oxidative phosphorylation. Besides 
regulation of genes involved in the catabolism of fatty 
acids, a key regulator of glycolysis, phosphofructokinase 
(Pfk) was down-regulated and tricarboxylic acid (TCA) 
cycle gene acotinase (Aco1) was up-regulated by chronic 
quercetin treatment. Of the two other adenine nucleotide 
translocators (Ant1 and Ant3), only Ant1 was expressed 
in the lung, but did not change significantly. In addition, 
Ppara, Ppard, Pparg, Pgc1a and Sirt1-7 were expressed 
in the lung but did not pass the significance filtering cri-
teria (data not shown).
Fatty acid catabolism gene expression. To confirm mi-
croarray gene expression results, we analyzed quercetin-
regulated genes related to the fatty acid catabolism path-
ways with quantitative real time PCR. We selected six 
genes (Lpl, Hmgcs2, Ech1, Acaa2, Acox1, Pcca) on the 
basis of regulation by quercetin and expression level in the 
microarray experiment. In addition, RNA isolated from 
lungs of rats fed a 0.1% quercetin diet for 41 weeks was 
used for qRT-PCR experiments. The genes with lowest 
variation within groups, and therefore the lowest p value 
in the microarray experiment (Ech1 and Hmgcs2), were 
both significantly up-regulated in the 0.1% quercetin 
group and/or the 1% quercetin group ( p < 0.05) (Fig. 4). 
Ech1 was significantly up-regulated in both the 0.1% and 
1% quercetin diet group, whereas Hmgcs2 was signifi-
cantly up-regulated only in the 0.1% quercetin diet group. 
Differential expression of Acaa2, Acox1, Pcca and Lpl 
using qRT-PCR was consistent with differential expres-
sion found in the microarray experiment. All genes were 
up-regulated by the 1% quercetin treatment; however, 
sample size (n = 6) was too small to reach significance 
using qRT-PCR ( p = 0.06 – 0.1).
Fatty acid catabolism plasma parameters. To further 
investigate the role of quercetin in fatty acid catabolism, 
analysis of fatty acid catabolism parameters was per-
formed in rat plasma. Consistent with microarray data 
and qRT-PCR results, chronic quercetin intervention in 
rats affected fatty acid catabolism plasma parameters. 
Plasma free fatty acid levels were significantly lower in 
the 1% quercetin group (Fig. 5a). The plasma levels of 
ketone bodies and triglycerides decreased with increas-
ing quercetin dose, but were not significantly different 
between control and quercetin groups (Fig. 5b, c).
Discussion
In this study we established for the first time in vivo mech-
anisms of action of quercetin in lungs of rats chronically 
exposed to dietary quercetin. The effects of the long-term 
Figure 4. Expression of genes in lungs of rats treated with a control 
diet, 0.1% quercetin diet (0.1% Q) and 1% quercetin diet (1% Q) 
for 41 weeks. (a) Expression of genes analyzed with qRT-PCR, us-
ing Hmbs as reference gene [using Rps26 as reference gene showed 
similar results (data not shown)]. (b) Expression of genes analyzed 
with microarray. Data represent relative mean ± SEM (n = 6), con-
trol diet is set to 1.0. Significance is shown for qRT-PCR data only. 
Differences between expression levels in the control and 1% quer-
cetin group in the microarray experiment were all significant (see 
supplemental Table S2 for p values). *p < 0.05 as compared with 
control group.
Figure 5. Plasma levels of fatty acid catabolism parameters in rats treated with a control diet, 0.1% quercetin diet (0.1% Q) or 1% quercetin 
diet (1% Q) for 41 weeks. Free fatty acids (a), triglycerides (b) and ketone bodies (c). Data represent mean ± SEM (n = 6). *p < 0.05.
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nutritional polyphenolic intervention were explored on a 
whole genome level allowing for unbiased exploration. 
Quercetin coordinately up-regulated genes involved in 
fatty acid catabolism pathways in lungs, and lowered 
fatty acid levels in plasma. This indicates that chronic di-
etary intake of quercetin led to a modulation of fatty acid 
metabolism in rats.
Quercetin was shown to regulate genes in every step 
of the breakdown of triglycerides to short chain carbon 
molecules (Fig. 3). The first step in degradation of tri-
glycerides is regulated by lipases that cleave fatty acids 
from glycerol for further processing in the cell. LPL is an 
extrahepatic lipase that is expressed in lungs [34], and is 
responsible for breakdown of plasma triglycerides from 
chylomicrons or lipoproteins. Entering the cell, fatty ac-
ids are converted to acyl CoA, and either degraded by 
peroxisomal beta-oxidation or transported into mitochon-
dria, possibly by VDAC1 [35], for further degradation. 
VDAC1 is an outer mitochondrial membrane channel that 
permits passage of all metabolites, except for small mem-
brane permeable compounds like oxygen, acetaldehyde 
and short chain fatty acids [36, 37]. After transportation 
into the mitochondrial matrix, acyl CoAs are degraded by 
a large set of beta-oxidation enzymes to yield acetyl CoA. 
Acetyl CoA can be utilized in the TCA cycle for energy 
production or converted to water-soluble transportable 
forms of acetyl CoA: acetoacetate and hydroxybutyrate 
by ketogenic enzymes HMGCS2, HMGL and HIBADH. 
Quercetin up-regulated Lpl, Vdac1, peroxisomal beta-ox-
idation enzymes (Acox1 and Ech1), mitochondrial beta-
oxidation enzymes (Acaa2 and Pcca) and ketogenic en-
zymes (Hmgcs2 and Hibadh). Peroxisomal Ech1 together 
with Hadh are part of the bifunctional protein. Hadh was 
up-regulated as well, but did not pass the significance 
filtering criteria (data not shown). In contrast to the up-
regulation of fatty acid catabolism pathways, adenine 
nucleotide translocator 2 (Ant2), together with one of 
the F0 subunits of ATP synthase, was down-regulated by 
quercetin. ATP synthase and ANT2 are responsible for 
the last steps of the oxidative phosphorylation, generating 
ATP by utilizing the inner membrane proton gradient and 
transporting ATP out of the mitochondrial matrix in ex-
change for ADP [38]. The fatty acid catabolism pathways 
will mostly be affected by quercetin when rate limiting 
steps are modulated. Quercetin regulated the rate limiting 
steps in peroxisomal beta-oxidation (Acox1 [39]) and ke-
togenesis (Hmgcs2 [40]); however, key regulators of mi-
tochondrial beta-oxidation, like Cpt1 [41] and Acad [39], 
were not affected. Vdac1 was up-regulated by quercetin, 
but whether the up-regulation of this highly abundant 
porin in the outer mitochondrial membrane is important 
in controlling mitochondrial beta-oxidation is largely un-
known. Vdac1 was shown to be up-regulated by acetyl-
l-carnitine in rat brain [42], and Vdac1 gene expression 
was also shown to be important in regulation of ATP and 
ADP fluxes into and out of mitochondria [43], indicating 
that regulation of Vdac1 on the gene expression level is of 
physiological relevance. Similarly, transcriptional regula-
tion of Lpl by pharmacological and physiological stimuli 
resulted in enhanced LPL enzyme activities [44].
The down-regulation of genes coding for ANT2 and 
ATP synthase in combination with the up-regulation of 
substrate usage by quercetin may suggest an uncoupling 
of oxidative phosphorylation. Classical uncoupling in 
brown adipose tissue is typically regulated by uncou-
pling protein UCP1, leading to heat production instead 
of ATP [45, 46]. Uncoupling can also function to con-
trol the NAD+/NADH ratio, thereby regulating metabolic 
processes dependent on these cofactors like ketogenesis 
[47, 48]. However, UCP1 was not significantly modified 
by the quercetin intervention, nor were UCP2 and UCP3. 
Quercetin-mediated down-regulation of ATP production 
and translocation in combination with an increase in ke-
tone body formation indicates that oxidation of fatty ac-
ids was not needed for energy production. Instead, this 
process seems to be taking care of an excess of fatty acids 
in the lungs, consequently producing ketone bodies that 
might be exhaled immediately via the pulmonary system 
and not being absorbed in plasma, explaining the fact 
that the level of plasma ketone bodies was not altered 
by quercetin. The increased expression of ketogenic en-
zymes can also be explained by the fact that glycolysis 
was decreased, as indicated by the down-regulation of 
one of the key glycolytic enzymes, Pfk. Therefore, TCA 
cycle intermediates are not available from glycolysis and, 
therefore, the excess of acetyl CoA can only be converted 
into ketone bodies. This is supported by the fact that suc-
cinyl CoA seems to be available as an intermediate for 
the TCA cycle, because Pcca, the enzyme involved in the 
formation of succinyl CoA from odd-chain fatty acids, 
was up-regulated, and Scot-S, the enzyme that consumes 
succinyl CoA to produce, together with acetoacetate, ace-
toacetyl CoA, was down-regulated. As a result, succinyl 
CoA probably complements for the decreased levels of 
intermediates from glycolysis.
The decrease in plasma free fatty acid levels in querce-
tin-treated rats is in line with other studies showing that 
dietary quercetin can lower free fatty acid levels in rab-
bits [49]. The major site for metabolism of fatty acids is 
the liver. Therefore, the contribution of lung fatty acid 
catabolism to systemic fatty acid levels is probably low. 
However, the decrease in plasma fatty acid levels is con-
sistent with the fact that quercetin modulates fatty acid 
metabolism in rats. Effects of quercetin on metabolism 
of energetic substrates were also reported by Mutch et al. 
[27]. Using affymetrix gene chips and cytochrome P450 
reductase knockout mice, they showed that after a short, 
4-h exposure to a 0.62% quercetin diet, amino acid me-
tabolism, lipid metabolism and glutathione metabolism 
pathways were altered in liver and intestines. Moreover, 
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genetically eliminating the expression of the phase I en-
zyme did not alter quercetin metabolism itself, but altered 
the tissue-specific location of differentially regulated ma-
jor metabolism pathways by quercetin [27].
Several other flavonoids have also been shown to inter-
fere with the homeostasis of fat storage and fatty acid 
metabolism. The strongest evidence for modulation of 
lipid metabolism by a flavonoid was found for epigal-
locatechin galate (EGCg), a polyphenol found in high 
levels in green tea. Dietary supplementation of EGCg or 
extracts of green tea reduced the increase in body weight 
and adipose tissue mass induced by feeding a high fat diet 
in rodents (reviewed in [7, 50]). The anti-lipidemic ef-
fect of EGCg could be explained by a decrease in energy 
uptake in the intestines [51, 52] and an increase in fatty 
acid oxidation rates [53, 54]. The physiological effects 
on energy expenditure and body weight by tea catechins, 
like EGCg, were accompanied by modulation of genes 
involved in fatty acid oxidation and fatty acid synthe-
sis. Green tea extracts increased the expression of fatty 
acid oxidation genes, medium chain acyl-CoA dehydro-
genase (Mcad) and acyl-CoA oxidase (Acox1), in liver 
and muscle in mice [54, 55]. In addition, tea catechins 
were shown to influence gene expression of important 
fatty acid synthesis genes; fatty acid synthase (Fas) and 
stearoyl-CoA dehydrogenase (Scd) were both down-regu-
lated by EGCg treatment in mice [52, 54]. Although in 
our study we did not challenge the animals with a high 
fat diet, we detected a similar up-regulation of fatty acid 
oxidation genes Acox1, Acaa2, Ech1 and Pcca by dietary 
quercetin in the lungs of rats.
Mechanistic insights on how quercetin can modulate 
fatty acid metabolism come from studies using models 
that show direct actions of quercetin on enzyme activi-
ties or indirect activation of regulating factors. Firstly, 
quercetin was shown to inhibit ATP synthase resulting 
in decreased mitochondrial and cellular ATP levels [56–
59]. NAD+/NADH ratios were also affected by quercetin 
in isolated perfused liver [60, 61]. Secondly, quercetin 
and other flavonoids are known to interact with several 
transcription factors and other regulatory proteins [62, 
63]. Among these, PPAR nuclear transcription factors or 
sirtuins may be targets for quercetin action [21, 64–66] 
in lungs of rats, mediating the observed effect of quer-
cetin on fatty acid metabolism. Interpretation of studies 
illustrating in vitro activation of regulatory proteins by 
quercetin, however, is hampered by the fact that querce-
tin aglycone is normally not present in plasma and tis-
sues of subjects [19, 26], unless local deconjugation of 
quercetin metabolites results in the formation of querce-
tin aglycone by enzymes with glucuronidase or sulfatase 
activity. Under certain physiological conditions, like in-
flammation and neoplastic growth, deconjugation of fla-
vonoid glucuronides can occur, liberating the flavonoid 
aglycone [67, 68].
An additional biological response of rat lungs to quer-
cetin supplementation seemed to be related to immune 
function. The highest fold changes of differential expres-
sion were found for genes coding for immunoglobulins. 
However, the variation between animals was large in 
both the control and quercetin groups. Cluster analysis 
of genes with highest fold change resulted in grouping 
of 20 immunoglobulin genes coordinately regulated in 
each animal. In two control animals and five quercetin 
animals immunoglobulin gene expression was relatively 
higher than in the remaining animals, demonstrating that 
immune response, possibly by an increase in lymphocyte 
infiltration in the lung, was enhanced in these animals. 
This may be a bona-fide response, but the power of the 
present study is insufficient to conclude this. This shows 
the importance of using individual hybridization of sam-
ples on microarrays. It also shows that pooling of samples 
before hybridization or labeling would have resulted in 
identifying immune response as the most important pro-
cess affected by quercetin treatment, and would lead to 
the fatty acid catabolism being unidentified.
Microarrays have evolved from a promising technique 
with a wide range of possibilities [69, 70] to a valu-
able and reproducible tool for assessing gene expression 
changes [71]. Application of microarrays to nutritional 
studies can give insights into how organisms react to di-
etary compounds [72]. A limitation of studying effects of 
dietary compounds on gene expression is that the changes 
induced by these compounds are most of the times small 
[73]. Unlike pharmaceutical interventions specifically 
directed at one high-affinity molecular target, dietary in-
tervention is less selective and generally results in small 
effects on gene expression. Using microarrays this prob-
lem can be overcome by studying a large number of genes 
at the same time. In this way, a combined effect of several 
small changes in the expression of genes belonging to a 
similar biological pathway can be easily detected. Other 
techniques, like RT-PCR and Northern blotting, would 
fail to identify such effects, because of the relatively low 
number of genes tested at the same time. Pathway analy-
sis software is in most cases indispensable in obtaining 
differentially modulated biological processes. A notable 
difficulty of assessing gene expression changes on a ge-
nome level is the problem of multiple testing. To obtain 
significant changes in gene expression the sample size 
should be sufficiently large, else correcting for multiple 
comparisons within the same experiment (e.g. 44 000 
comparisons on one microarray) does not yield signifi-
cant data. In other words, the proportion of false posi-
tives in the dataset is large when thousands of genes are 
analyzed simultaneously. Methods for correcting for false 
discovery rate, like Benjamini-Hochberg, Holm and Bon-
ferroni methods [74], are commonly used. Also Bayesian 
approaches are used that take into account the expression 
level of the genes for statistical analysis, assuming simi-
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lar variances in genes with similar expression levels [75]. 
However, the costs for microarray experiments are most 
of the time still too high to allow for a high number of 
biological replicates. We prioritized the data on the basis 
of p value, and used the genes with the lowest p values 
( p < 0.05) for further analysis, without using statistical 
multiple correction techniques. When we combined the 
small effects of the most significantly changed genes into 
common biological pathways, we were able to identify 
effects of quercetin on fatty acid catabolism pathways. 
Individual gene expression changes were confirmed with 
qRT-PCR, and a decrease in plasma fatty acid levels indi-
cated that quercetin altered fatty acid metabolism in rats. 
This biological validation of microarray data with inde-
pendent techniques is the most powerful way to eliminate 
the possible misinterpretation of processes being false 
positively assigned as being regulated [76].
In conclusion, this study shows that quercetin induces 
fatty acid catabolism pathways in rat lung. In addition, 
quercetin showed an effect similar to uncoupling of oxi-
dative phosphorylation combined with an up-regulation 
of genes involved in the formation of ketone bodies. 
Quercetin is, therefore, newly identified as another flavo-
noid that can regulate fatty acid metabolism in vivo.
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